221 related articles for article (PubMed ID: 26113304)
1. Emerging drugs for the treatment of bone metastasis.
Pantano F; Iuliani M; Zoccoli A; Fioramonti M; De Lisi D; Fioroni I; Ribelli G; Santoni M; Vincenzi B; Tonini G; Santini D
Expert Opin Emerg Drugs; 2015; 20(4):637-51. PubMed ID: 26113304
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapies in bone metastasis.
Clément-Demange L; Clézardin P
Curr Opin Pharmacol; 2015 Jun; 22():79-86. PubMed ID: 25935860
[TBL] [Abstract][Full Text] [Related]
3. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.
Hiraga T
Expert Opin Investig Drugs; 2016; 25(3):319-34. PubMed ID: 26778342
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in bone-targeted therapies of metastatic prostate cancer.
Deng X; He G; Liu J; Luo F; Peng X; Tang S; Gao Z; Lin Q; Keller JM; Yang T; Keller ET
Cancer Treat Rev; 2014 Jul; 40(6):730-8. PubMed ID: 24767837
[TBL] [Abstract][Full Text] [Related]
5. [Molecular basis of bone metastasis formation and its targeted therapy].
Tímár J
Magy Onkol; 2010 Mar; 54(1):59-64. PubMed ID: 20350869
[TBL] [Abstract][Full Text] [Related]
6. New anti-resorptives and antibody mediated anti-resorptive therapy.
Farrier AJ; Sanchez Franco LC; Shoaib A; Gulati V; Johnson N; Uzoigwe CE; Choudhury MZ
Bone Joint J; 2016 Feb; 98-B(2):160-5. PubMed ID: 26850419
[TBL] [Abstract][Full Text] [Related]
7. Advances in prevention and treatment of bone metastases in prostate cancer. Role of RANK/RANKL inhibition.
Gomez-Veiga F; Ponce-Reixa J; Martinez-Breijo S; Planas J; Morote J
Actas Urol Esp; 2013 May; 37(5):292-304. PubMed ID: 23246105
[TBL] [Abstract][Full Text] [Related]
8. Bone targeted therapies in metastatic castration-resistant prostate cancer.
Rajpar S; Fizazi K
Cancer J; 2013; 19(1):66-70. PubMed ID: 23337759
[TBL] [Abstract][Full Text] [Related]
9. Bone-Targeted Therapies in Cancer-Induced Bone Disease.
Sousa S; Clézardin P
Calcif Tissue Int; 2018 Feb; 102(2):227-250. PubMed ID: 29079995
[TBL] [Abstract][Full Text] [Related]
10. Effects of bone-targeted agents on cancer progression and mortality.
Coleman R; Gnant M; Morgan G; Clezardin P
J Natl Cancer Inst; 2012 Jul; 104(14):1059-67. PubMed ID: 22752060
[TBL] [Abstract][Full Text] [Related]
11. Management of castration-resistant prostate cancer: bisphosphonates and emerging therapies.
Saad F; Colombel M
Expert Rev Anticancer Ther; 2010 Dec; 10(12):1991-2002. PubMed ID: 21110764
[TBL] [Abstract][Full Text] [Related]
12. Basic and clinical associations between bone and cancer.
He F; Matsumoto Y
Immunol Med; 2020 Sep; 43(3):103-106. PubMed ID: 32301686
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of bone metastases in breast cancer patients--an update.
Jacobs C; Simos D; Addison C; Ibrahim M; Clemons M
Expert Opin Pharmacother; 2014 Jun; 15(8):1109-18. PubMed ID: 24673572
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence.
Santini D; Stumbo L; Spoto C; D'Onofrio L; Pantano F; Iuliani M; Fioramonti M; Zoccoli A; Ribelli G; Virzì V; Vincenzi B; Tonini G
Breast Cancer Res; 2015 Sep; 17(1):121. PubMed ID: 26328589
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.
Li J; Rugo HS
Breast Dis; 2011; 33(2):83-92. PubMed ID: 22142661
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy options for treatment of bone metastases; beyond bisphosphonates.
Buijs JT; Kuijpers CC; van der Pluijm G
Curr Pharm Des; 2010; 16(27):3015-27. PubMed ID: 20722621
[TBL] [Abstract][Full Text] [Related]
17. Novel bone-targeted strategies in oncology.
Vallet S; Smith MR; Raje N
Clin Cancer Res; 2010 Aug; 16(16):4084-93. PubMed ID: 20643782
[TBL] [Abstract][Full Text] [Related]
18. Progress in the treatment of bone metastases in cancer patients.
Mackiewicz-Wysocka M; Pankowska M; Wysocki PJ
Expert Opin Investig Drugs; 2012 Jun; 21(6):785-95. PubMed ID: 22500564
[TBL] [Abstract][Full Text] [Related]
19. [Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer].
Taguchi T
Clin Calcium; 2011 Mar; 21(3):429-38. PubMed ID: 21358065
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid: past, present and future roles in cancer treatment.
Saad F
Future Oncol; 2005 Apr; 1(2):149-59. PubMed ID: 16555985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]